|Lipodystrophy and Emery-Dreifuss muscular dystrophy
Nov 20, 2002
Dear Dr. Dieterich,
I have Emery-Dreifuss muscular dystrophy and my condition is associated with a marked absence of subcutaneous body fat. However, I have not experienced any facial lipodystrophy. I have an autosomal dominant mutation within the gene, nuclear lamin. (R527P) This mutation alters the receptor for sterol response element binding protein 1 (srebp1), and as a consequence, my binding of srebp1 is reduced by nearly 75. It has been recently discovered that patients on HAART experience a lowering of srebp1 levels, and this is suspected to contribute to lipodystrophy. My question for you is that I am wondering if any researchers have attempted to design a medication that upregulates the levels of srebp1. Could upregulation of srebp1 help to alleviate the lipodystrophy symptoms in patients with nuclear lamin mutations, as well as patients on HAART?
Response from Dr. Dieterich
Good question! I really have no information about that topic. Certainly there is no clinical data about it. It would be a good avenue for the basic scientists to investigate. Maybe someone will see it here and go for it! Thanks for a very intelligent question! DTD
Which drug causes Liprodystrophy?
Cosmetic Surgery for Wasted Butt?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.